Sodium thiosulfate anhydrous
Term · Oncology and biomedicine · MLC-T-ONC-007854
A drug used to reduce the risk of hearing loss in children aged 1 month and older who are receiving cisplatin (a type of anticancer drug) for solid tumors that have not spread to other parts of the body. It is also being studied in the prevention and treatment of other conditions. Sodium thiosulfate anhydrous is a type of chemoprotective agent. Also called Pedmark.
| Identifier | MLC-T-ONC-007854 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Pedmark |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007854",
"term": "Sodium thiosulfate anhydrous",
"field": "Oncology and biomedicine",
"definition": "A drug used to reduce the risk of hearing loss in children aged 1 month and older who are receiving cisplatin (a type of anticancer drug) for solid tumors that have not spread to other parts of the body. It is also being studied in the prevention and treatment of other conditions. Sodium thiosulfate anhydrous is a type of chemoprotective agent. Also called Pedmark.",
"synonyms": [
"Pedmark"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/sodium-thiosulfate-anhydrous/"
}
Record 15,153 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.